Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Low vs. high hemoglobin trigger for Transfusion in Vascular surgery (TV): a randomized clinical feasibility trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Clonal hematopoiesis in elderly twins: concordance, discordance and mortality

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Skin colonization by circulating neoplastic clones in cutaneous T-cell lymphoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The preleukemic TCF3-PBX1 gene fusion can be generated in utero and is present in ≈0.6% of healthy newborns

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  1. Should antidepressants be used for major depressive disorder?

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. The PANSAID Randomized Clinical Trial: A pre-planned 1-year follow-up regarding harm

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Dr. Uhre et al. Reply

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Current guidelines advocate to limit red-cell transfusion during surgery, but the feasibility and safety of such strategy remains unclear as the majority of evidence is based on postoperative stable patients. We assessed the effects of a protocol aiming to restrict red-cell transfusion throughout hospitalization for vascular surgery. Fifty-eight patients scheduled for lower limb-bypass or open abdominal aortic aneurysm repair were randomized upon hemoglobin drop below 9.7g/dL to a low-trigger (hemoglobin<8.0 g/dL) vs. high-trigger (hemoglobin<9.7 g/dL) for red-cell transfusion. Intraoperative oxygen desaturation in cerebral- and muscle tissue was assessed by near-infrared spectroscopy. An explorative outcome included data on death and major vascular complications from a nationwide registry. The primary outcome, mean hemoglobin within 15 days of surgery, was significantly lower in the low-trigger group: 9.46 g/dL vs. 10.33 g/dL in the high-trigger group (mean difference, 0.87g/dL; P=0.022; longitudinal analysis) as were units of red-cells transfused (median [interquartile range(IQR)], 1 [0-2] vs. 3 [2-6]; P=0.0015). While the duration and magnitude of cerebral oxygen desaturation from baseline increased in the low-trigger group (median [IQR], 421 minutes*% [42-888] vs. 127 [11-331]; P=0.0036), muscle oxygenation was unaffected. The low-trigger associated to a higher rate of death or major vascular complications: 19/29 vs. 8/29 (hazard ratio, 3.20; P=0.006) and fewer days alive outside hospital within 90 days (median [IQR], 76 [67-82] vs. 82 [76-84] days; P=0.049). In conclusion, a perioperative protocol restricting red-cell transfusion successfully separated hemoglobin levels and red-cell units transfused. Exploratory outcomes suggested potential harm with the low-trigger and warrants further trials in vascular surgery before such strategy is universally adopted. ( identifier NCT02465125).

Udgave nummer25
Sider (fra-til)2639-2650
StatusUdgivet - 11 mar. 2019

Bibliografisk note

Copyright © 2019 American Society of Hematology.

ID: 56914766